CRVS
CRVS
US2210151005
Corvus Pharmaceuticals, Inc.
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
884.95M EUR
1.26B EUR
1.23B EUR
575.16M EUR
Enterprise Value
644.37M EUR
1.24B EUR
1.19B EUR
571.53M EUR
Valuation Multiples
Trailing P/E
--
--
--
--
Forward P/E
-9.85x
--
--
--
Price to Sales
--
--
--
--
Price to Book
3.93x
5.58x
5.11x
9.4x
EV/Revenue
--
--
--
--
EV/EBITDA
-11.34x
--
--
--
Price to FCF (P/FCF)
--
--
--
--
EV/FCF
--
--
--
--
FCF Yield
-3.1%
-3.6%
-2.86%
-4.29%
ende